IL1B and oral cavity squamous cell carcinoma: For example, interleukin-1 beta (IL-1β), a well-known mediator of chronic inflammation, has been identified as a salivary biomarker for oral squamous cell carcinoma [117], and increased IL-1β levels have been related to the increased severity of oral malignant transformation in in vivo models [118].